Our approach to science and technology is based on combining diversity, quality, and efficiency. Our platforms are set up to enable the parallel and effective development and manufacturing of a variety of sophisticated products.
The technological platforms and scientific methodologies we apply include process and analytics development for biopharmaceutical, as well as chemically-synthesized and diagnostics products.
We have established a unique R&D laboratory, which enables the rapid development of high-quality therapeutic monoclonal antibodies.
Insight in-house infrastructure, have shortened the typical time required to perform the mandatory interdisciplinary iterative steps to develop Orphan drugs and biosimilar products.